Skip to content

sleep problem and neurodevelopmental disorders in children

sleep structure and its correlation with clinical symptoms in children with different neurodevelopmental disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20250310002
Enrollment
600
Registered
2025-03-10
Start date
2023-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD TD Sleep ADHD TD CSHQ Allergy Vitamin D

Interventions

Per the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), every participant fulfilled the clinical diagnostic standards for ADHD,Per the 5th edition of the Diagnostic a
ADHD group,TD group,control group

Sponsors

Sun Hao
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 14 Years

Inclusion criteria

Inclusion criteria: One: 1. Aged 4-14 years old, regardless of gender; 2. Meet the diagnostic criteria for ADHD; 3. All enrolled children have completed the SNAP scale, Conner parent questionnaire, sensory integration ability scale, and WEISS developmental scale; agree to voluntarily participate in this study and sign the informed consent form; Two: 1. Aged 4-14 years old, regardless of gender; 2. Meet the diagnostic criteria for TD; 3. All enrolled children have completed the SNAP scale, Conner parent questionnaire, sensory integration ability scale, and WEISS developmental scale; agree to voluntarily participate in this study and sign the informed consent form; Three: 1. Aged 4-14 years old, regardless of gender; 2. No neurodevelopmental disease, organic disease, etc.; 3. Agree to participate in this study voluntarily and sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1. Children with visual, hearing, and pronunciation disorders 2: Children with other neurological, mental diseases or congenital malformations 3: Children with serious diseases of endocrine, liver and kidney function, blood system, etc.

Design outcomes

Primary

MeasureTime frame
sleep problem CSHQ Enrollment Patient reported outcome using a questionnaire interview

Secondary

MeasureTime frame
ADHD and TD Symptoms Enrollment Patient reported outcome using a questionnaire interview

Countries

China

Contacts

Public ContactPanpan Zhang

dalian medical university

18098005343@163.com18098005343

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026